Best in Biotech 5 Aug 2025 10 oncology deals in 2025 spotlight where industry leaders are betting big …systemic adverse events. The company’s technology has already attracted interest from Gilead, which paid out $43.5 million in March 2024 for the rights to develop and commercialize Xilio’s tumor-activated IL-12… August 5, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2022 Study results reveal bleeding episodes are significantly reduced by hemophilia drug …67 participants exposed to a least one dose of fitusiran, the most common adverse events (in less than six participants) were increased alanine aminotransferase, nasopharyngitis, and upper respiratory tract infection…. July 11, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 22 Oct 2021 Gene-Edited T Cell Therapy Players Battle Safety Doubts …Industry experts see these events as a reality check for the nascent field. Off-the-shelf treatments that use genetically engineered T cells to treat diseases suffered a blow to their image… October 22, 2021 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
In Depth 23 Apr 2025 The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval …patients with relapsing-remitting multiple sclerosis over a 24-week period. Additionally, in terms of safety, there were no serious treatment-emergent adverse events recorded in the 80mg once daily dosage group, which… April 23, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 8 Mar 2024 AI immune system mapping to boost drug discovery …why. “The ability to leverage computational models to find the features that underscore the difference between the responders and non-responders, between toxic events and non-toxic events, between healthy people and… March 8, 2024 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jul 2022 Biogen’s New Drug Application for first treatment of rare form of neurological disease accepted by FDA …meaningfully slow the rapid progression of their disease and the impact it has on their lives.” Pain in extremities In the 12-month data, the most common adverse events (AEs) in… July 28, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 21 May 2020 What 2019 Can Teach About European Biotech Investments Going Forward …at where European biotech investments were heading in 2019. From there, we can then make some guesses about how the industry will evolve. Last year saw some groundbreaking events in… May 21, 2020 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jan 2018 This Skin Patch Could Slow the Rate of Antibiotic Resistance …& Melinda Gates Foundation to target its TCR technology at tuberculosis. Da Volterra got €20M from the EU to speed up the development of its medical device that prevents Clostridium… January 8, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Weekly Roundup 10 Nov 2023 Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs …be generally well-tolerated, and there were no serious adverse events or deaths recorded in the trial. This was the first study to address a World Health Organization priority pathogen that… November 10, 2023 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2022 Study data for glioblastoma treatment confirms safety and tolerability profile …tolerated. Dosimetric analysis demonstrates that radiation exposure to key organs is well within acceptable safety limits. The most frequent treatment emergent adverse events (TEAEs) were decreased lymphocyte count, fatigue, headache… September 22, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 8 Feb 2024 Could we see a new dawn for hair loss treatments? …potential side effects and risks, including serious infections, increased risk of death in older individuals with heart disease risk factors, and the possibility of major cardiovascular events. A year after… February 8, 2024 - 8 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Jan 2024 Eight mental health biotech companies trying to make a difference to people’s lives …in depressive symptoms and associated functional impairment. The drug was also well-tolerated with long-term dosing, showing low rates of adverse events and discontinuations due to adverse events. Furthermore, no new… January 25, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email